Long-term valacyclovir treatment and immune modulation for Herpes-associated erythema multiforme

Jurate Staikuniene; Jurate Staneviciute

doi:10.5114/ceji.2015.54604

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

3/2015
vol. 40

Send email

Copy url:

abstract:

Review paper

Long-term valacyclovir treatment and immune modulation for Herpes-associated erythema multiforme

Jurate Staikuniene

,

Jurate Staneviciute

(Cent Eur J Immunol 2015; 40 (3): 387-390)

DOI: https://doi.org/10.5114/ceji.2015.54604

Online publish date: 2015/10/15

View full text Get citation

PlumX metrics:

Objective: Erythema multiforme (EM) is an immune-mediated condition characterized by the appearance of target-like lesions on the skin and often accompanied by erosions or bullae involving the oral, genital, and/or ocular mucosae. 70% of recurrent EM cases are associated with HSV reactivation and it is labelled as herpes-associated erythema multiforme (HAEM). Recurrences are seen in approximately 20-25% of EM cases and managing these conditions are challenging for both the patient and the doctor. The effectiveness of antiviral drugs is proven for Herpes simplex infection, however most patients use a multiplicity of alternative and complementary therapies.

Clinical presentation: We present clinical data of 3 patients with recurrent HAEM managed by long-term valacyclovir therapy and immunostimulation with Echinacea or replacement immunoglobulin therapy in the case of IgG1 subclass deficiency. The presented cases have demonstrated that immune mechanisms are relevant for HAEM recurrences.

Conclusions: The immune abnormalities, such as antibody deficiency, in the patients with HSV-associated EM can lead to frequent relapses of disease and should be evaluated. Long-term antiviral therapy with immunomodulation can control the relapses of HAEM.

keywords:

Long-term valacyclovir treatment and immune modulation for Herpes-associated erythema multiforme

Jurate Staikuniene , Jurate Staneviciute

erythema multiforme, herpes-associated erythema multiforme, HAEM, HSV infection

Jurate Staikuniene

,

Jurate Staneviciute